Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Petrie

Showing results (521-530 of 557) with videos related to

Pageof 56
Sort By:
European Journal of Heart Failure|December 12, 2018
Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the AmericasPooja Dewan, Pardeep S Jhund, Li Shen, et al.
Circulation. Heart Failure|December 21, 2018
Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical RevascularizationNadia Bouabdallaoui, Susanna R Stevens, Torsten Doenst, et al.
Journal of the American College of Cardiology|December 12, 2024
Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HFJawad H Butt, Alasdair D Henderson, Pardeep S Jhund, et al.
European Journal of Heart Failure|May 6, 2025
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESCGianluigi Savarese, Gabriele G Schiattarella, Felix Lindberg, et al.
Circulation. Cardiovascular Interventions|August 1, 2019
Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary SyndromeMatthew M Y Lee, Mark C Petrie, Paul Rocchiccioli, et al.
Open Heart|February 27, 2021
Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populationsMatthew M Y Lee, Mark C Petrie, Paul Rocchiccioli, et al.
Nature Medicine|August 27, 2023
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trialBarry A Borlaug, Dalane W Kitzman, Melanie J Davies, et al.
European Journal of Heart Failure|March 5, 2026
Characterising the heterogeneity of heart failure with preserved ejection fraction: moving beyond subgroups and distinguishing disease from riskFardad Soltani, Nicholas Black, Joshua Bradley, et al.
European Journal of Heart Failure|March 2, 2026
SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart FailureRoss T Campbell, Joanna Osmanska, Kieran F Docherty, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
Pageof 56

Showing results (521-530 of 557) with videos related to

Sort By:
Pageof 56
European Journal of Heart Failure|December 12, 2018
Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the AmericasPooja Dewan, Pardeep S Jhund, Li Shen, et al.
Circulation. Heart Failure|December 21, 2018
Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical RevascularizationNadia Bouabdallaoui, Susanna R Stevens, Torsten Doenst, et al.
Journal of the American College of Cardiology|December 12, 2024
Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HFJawad H Butt, Alasdair D Henderson, Pardeep S Jhund, et al.
European Journal of Heart Failure|May 6, 2025
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESCGianluigi Savarese, Gabriele G Schiattarella, Felix Lindberg, et al.
Circulation. Cardiovascular Interventions|August 1, 2019
Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary SyndromeMatthew M Y Lee, Mark C Petrie, Paul Rocchiccioli, et al.
Open Heart|February 27, 2021
Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populationsMatthew M Y Lee, Mark C Petrie, Paul Rocchiccioli, et al.
Nature Medicine|August 27, 2023
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trialBarry A Borlaug, Dalane W Kitzman, Melanie J Davies, et al.
European Journal of Heart Failure|March 5, 2026
Characterising the heterogeneity of heart failure with preserved ejection fraction: moving beyond subgroups and distinguishing disease from riskFardad Soltani, Nicholas Black, Joshua Bradley, et al.
European Journal of Heart Failure|March 2, 2026
SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart FailureRoss T Campbell, Joanna Osmanska, Kieran F Docherty, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
Pageof 56